Literature DB >> 3964756

Altered bile acid metabolism in nonobese, spontaneously diabetic (NOD) mice.

K Uchida, S Makino, T Akiyoshi.   

Abstract

Cholesterol and bile acid metabolism was examined in nonobese, spontaneously diabetic (NOD) female mice before and after the development of diabetes. After the development of glucosuria, the plasma and liver cholesterol levels, gallbladder bile weight after 5-h fasting, biliary cholesterol, phospholipid and bile acid concentrations, the lithogenic index, the pool size of bile acids, and fecal sterol excretion markedly increased, but fecal bile acid excretion and fractional turnover rates for the cholic acid and chenodeoxycholic acid groups decreased. The distribution percentage of bile acids in the small intestine did not change, but it increased in the gallbladder and decreased in the large intestine. One striking finding was a change in the bile acid composition: increases were recorded in cholic and deoxycholic acids while decreases occurred in bile acids derived from chenodeoxycholic acid, such as beta-muricholic and ursodeoxycholic acids in the bile and alpha-muricholic, beta-muricholic, omega-muricholic, and hyodeoxycholic acids in the feces. Therefore, the cholic acid group/chenodeoxycholic acid group (CA/CDCA) ratio increased in the bile, feces, and small and large intestines after the development of diabetes. These changes were very similar to those observed in alloxan-treated mice, suggesting that the changes found in NOD mice are caused by insulin deficiency.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3964756     DOI: 10.2337/diab.34.1.79

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  27 in total

Review 1.  Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs.

Authors:  Tiara R Ahmad; Rebecca A Haeusler
Journal:  Nat Rev Endocrinol       Date:  2019-10-15       Impact factor: 43.330

2.  Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS.

Authors:  Yazen Alnouti; Iván L Csanaky; Curtis D Klaassen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-09-03       Impact factor: 3.205

3.  Type 1 diabetes is associated with an increase in cholesterol absorption markers but a decrease in cholesterol synthesis markers in a young adult population.

Authors:  Ivana Semova; Amy E Levenson; Joanna Krawczyk; Kevin Bullock; Kathryn A Williams; R Paul Wadwa; Amy S Shah; Philip R Khoury; Thomas R Kimball; Elaine M Urbina; Sarah D de Ferranti; Franziska K Bishop; David M Maahs; Lawrence M Dolan; Clary B Clish; Sudha B Biddinger
Journal:  J Clin Lipidol       Date:  2019-09-25       Impact factor: 4.766

4.  Delineation of biochemical, molecular, and physiological changes accompanying bile acid pool size restoration in Cyp7a1(-/-) mice fed low levels of cholic acid.

Authors:  Ryan D Jones; Joyce J Repa; David W Russell; John M Dietschy; Stephen D Turley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-24       Impact factor: 4.052

Review 5.  The Contributing Role of Bile Acids to Metabolic Improvements After Obesity and Metabolic Surgery.

Authors:  Farnaz Fouladi; James E Mitchell; Joseph A Wonderlich; Kristine J Steffen
Journal:  Obes Surg       Date:  2016-10       Impact factor: 4.129

6.  Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice.

Authors:  Jan Freark de Boer; Wijtske Annema; Marijke Schreurs; Jelske N van der Veen; Markus van der Giet; Niels Nijstad; Folkert Kuipers; Uwe J F Tietge
Journal:  J Lipid Res       Date:  2011-12-18       Impact factor: 5.922

7.  Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin.

Authors:  Marlene Wewalka; Mary-Elizabeth Patti; Corinne Barbato; Sander M Houten; Allison B Goldfine
Journal:  J Clin Endocrinol Metab       Date:  2014-01-16       Impact factor: 5.958

8.  Bile acid sequestrants for lipid and glucose control.

Authors:  Bart Staels; Yehuda Handelsman; Vivian Fonseca
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

Review 9.  Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration.

Authors:  Bart Staels; Vivian A Fonseca
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

10.  All-trans retinoic acid regulates hepatic bile acid homeostasis.

Authors:  Fan Yang; Yuqi He; Hui-Xin Liu; Jessica Tsuei; Xiaoyue Jiang; Li Yang; Zheng-Tao Wang; Yu-Jui Yvonne Wan
Journal:  Biochem Pharmacol       Date:  2014-08-28       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.